RCM TECHNOLOGIES Reports Record FY2022 Q4 Earnings Results on March 15 2023.
March 18, 2023

Earnings Overview
RCM TECHNOLOGIES ($NASDAQ:RCMT) reported their FY2022 Q4 earnings results as of March 15 2023, announcing total revenue of USD 4.8 million for the quarter ending December 31 2022, a decrease of 18.9% compared to the same period in the previous year. Net income for the quarter was USD 70.2 million, a 8.2% increase year over year.
Transcripts Simplified
The financial statements and earnings transcripts for RCM Technologies are available through the company’s investor relations website. To access them, visit their Investor Relations page, which can be found by visiting https://www.rcmtechnologies.com/investor-relations/. You can find the earnings transcripts on the Events & Presentations tab in the left-hand side menu. The transcripts are arranged in chronological order and include both quarterly and annual reports.
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Rcm Technologies. More…
Total Revenues | Net Income | Net Margin |
284.68 | 20.89 | 7.3% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Rcm Technologies. More…
Operations | Investing | Financing |
28.44 | -4.98 | -23.13 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Rcm Technologies. More…
Total Assets | Total Liabilities | Book Value Per Share |
87.96 | 56 | 3.73 |
Key Ratios Snapshot
Some of the financial key ratios for Rcm Technologies are shown below. More…
3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
14.2% | 63.1% | 10.0% |
FCF Margin | ROE | ROA |
10.0% | 48.5% | 20.2% |
Price History
On Wednesday, March 15, 2023, RCM TECHNOLOGIES reported record earnings for the fourth quarter of FY2022. This news sent their stock opening at $12.7 and closing at $12.5, down by 3.7% from its last closing price of 12.9. Despite this slight dip from the previous day’s closing price, RCM Technologies’ stock is still up nearly 10% this quarter, indicating a strong performance for the company. As the company continues to build on its success and looks to the future, it’s clear that this stock will be a great investment for anyone looking to get in on an up-and-coming tech company. Live Quote…
Analysis
GoodWhale has analysed the financials of RCM TECHNOLOGIES and our Star Chart shows that it is classified as a ‘gorilla’. This classification is given to companies that have achieved stable and high revenue or earning growth due to its strong competitive advantage. Thus, this makes it an attractive investment for those who are interested in long-term growth and capital appreciation. What makes RCM TECHNOLOGIES even more attractive, is its high health score of 8/10 with regard to its cashflows and debt. This means that RCM TECHNOLOGIES is capable to sustain future operations in times of crisis. Furthermore, GoodWhale’s analysis shows that RCM TECHNOLOGIES is strong in growth and profitability, is medium in asset and weak in dividend. Thus, this company has the potential to generate superior returns for investors over the long-term, making it an attractive investment for those looking for high returns. More…
Peers
The company has a strong presence in North America, Europe, and Asia. RCM Technologies Inc’s competitors include Jangho Group Co Ltd, Calian Group Ltd, and Peoplein Ltd.
– Jangho Group Co Ltd ($SHSE:601886)
JHG is a leading investment company with a focus on the healthcare sector. The company has a market capitalization of 8.92 billion as of 2022 and a return on equity of -9.2%. JHG has a diversified portfolio of healthcare investments, including hospitals, clinics, and nursing homes. The company also has a significant presence in the pharmaceutical and biotechnology industries.
– Calian Group Ltd ($TSX:CGY)
Calian Group Ltd is a Canadian professional services company with over 30 years of experience in the provision of health, training, and technology solutions. The company has a market cap of 648.65M as of 2022 and a Return on Equity of 4.41%. Calian employs over 2,600 people in Canada, the United States, and the United Kingdom. The company’s health solutions include primary care, health promotion, and disease prevention services. Calian’s training solutions include online and classroom training, as well as simulation-based training. The company’s technology solutions include systems engineering, software development, and network integration services.
– Peoplein Ltd ($ASX:PPE)
As of 2022, Peoplein Ltd has a market cap of 310.55M and a Return on Equity of 13.79%. The company is a provider of human resources solutions and services.
Summary
Investors in RCM Technologies were given mixed news when the company reported their FY2022 Q4 earnings results as of March 15 2023. Total revenue for the quarter was USD 4.8 million, a decrease of 18.9% when compared to the same period last year. On the other hand, net income for the quarter showed an increase of 8.2% year over year.
Unfortunately, this news caused the stock price to move down on the same day, leaving investors in a state of uncertainty. Ultimately, it is difficult to make an investing decision based on these results without further analysis.
Recent Posts